Cyactiv Joint
Natural health product licensed in Canada
- Licence holder
- Cerule International LLC
- NPN or DIN-HM
- 80091374
- Status
- Active licence
- Licence date
- 20 March 2019
- Revision date
- 6 December 2021
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Arthrospira platensis Source : Cellule brisée Extract : Matériel brut sec Extraction ratio : 3:1 Dry plant equivalent : 375 mg | 125 mg | Not calculated |
| Prunus cerasus Source : Fruit | 120 mg | Not calculated |
| Boswellia serrata Source : Gum oleoresin Extract : Matériel brut sec Extraction ratio : 7:1 Dry plant equivalent : 700 mg Potency : 35 % Boswellic acids | 100 mg | Not calculated |
Non-medicinal ingredients
Poudre d'Oryza Sativa (Riz), Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Capsule | 2 days |
Uses authorised in Canada
Text supplied in English because no French text is available.
(NEM) Helps provide relief from joint pain due to moderate intensity aerobic exercise as quickly as the first day.(NEM) Helps reduce levels of CTX-II, a biomarker of cartilage/joint degradation, due to moderate intensity aerobic exercise.
Source of antioxidants. Research-proven to help reduce joint pain in 7-10 days. Starts to help reduce pain and increase joint flexibility at 7 days. Helps reduce joint pain and stiffness (associated with osteoarthritis).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80091374
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed. Photograph the packaging